Treatment of chronic hepatitis B with interferon-alpha: cost-effectiveness in developing countries. | IMSEAR

Main content 1 Search 2 Footer 3

+A A -A High contrast

Treatment of chronic hepatitis B with interferon-alpha: cost-effectiveness in developing countries.

Aggarwal, Rakesh; Ghoshal, U C; Naik, S R.

Article in En | IMSEAR | ID: sea-118569

Subject(s)

Adult; Antiviral Agents/economics; Cost-Benefit Analysis; Developing Countries; Disease Progression; Drug Costs; Female; Hepatitis B, Chronic/drug therapy; Humans; India; Interferon-alpha/economics; Male; Markov Chains; Quality of Life; Treatment Outcome

Search on Google

Full text: 1 Index: IMSEAR Main subject: Antiviral Agents / Quality of Life / Female / Humans / Male / Markov Chains / Treatment Outcome / Interferon-alpha / Drug Costs / Cost-Benefit Analysis Type of study: Health_economic_evaluation Country/Region as subject: Asia Language: En Year: 2002 Type: Article

Search on Google

Full text: 1 Index: IMSEAR Main subject: Antiviral Agents / Quality of Life / Female / Humans / Male / Markov Chains / Treatment Outcome / Interferon-alpha / Drug Costs / Cost-Benefit Analysis Type of study: Health_economic_evaluation Country/Region as subject: Asia Language: En Year: 2002 Type: Article